Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT07408713Not Yet Recruiting

Neurocognitive Deficit After Paediatric Transplantation: Understanding the Role of Environment and Physical Function

Role: collaborator

NCT06624267Not Yet Recruiting

Test of Reproducibility of [15O]H20-PET Assessment of Brain Perfusion

Role: collaborator

NCT06628297Not Yet Recruiting

Comparison of Differencens in VO2-max, Perfusion of the Heart and Brain and Cognitive Performance Between Patients with Type 2 Diabetes and Healthy Age Matched Controls.

Role: collaborator

NCT06373471Not ApplicableRecruiting

Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment

Role: collaborator

NCT04289350Completed

Day to Day Variation in Fetal Heart Rate Variability

Role: collaborator

NCT04288037Unknown

Fetal Heart Rate Variability and Fetal Growth Restriction

Role: collaborator

NCT04323865Completed

Fetal Heart Rate Variability

Role: collaborator

NCT01819649Not ApplicableCompleted

Selenium in the Prevention of Cancer

Role: collaborator

NCT01316497Not ApplicableCompleted

Acute Kidney Injury in Children Operated for Congenital Heart Disease

Role: collaborator

All 9 trials loaded